Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Q. Zhang, C. Chen, M. Swaroop, M. Xu, L. Wang, J. Lee, M. Pradhan, M. Shen, Z. Luo, Y. Xu, W. Huang, W. Zheng, Y. Ye
This study shows heparan sulfate aids SARS-CoV-2 entry and identifies drugs that inhibit this process in vitro.
bioRxiv · Jul 14, 2020Cell Biology